373 related articles for article (PubMed ID: 18391200)
1. Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain.
Wells M; Tidow H; Rutherford TJ; Markwick P; Jensen MR; Mylonas E; Svergun DI; Blackledge M; Fersht AR
Proc Natl Acad Sci U S A; 2008 Apr; 105(15):5762-7. PubMed ID: 18391200
[TBL] [Abstract][Full Text] [Related]
2. Multiple conformations of full-length p53 detected with single-molecule fluorescence resonance energy transfer.
Huang F; Rajagopalan S; Settanni G; Marsh RJ; Armoogum DA; Nicolaou N; Bain AJ; Lerner E; Haas E; Ying L; Fersht AR
Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20758-63. PubMed ID: 19933326
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case.
Ithuralde RE; Turjanski AG
PLoS One; 2016; 11(1):e0144284. PubMed ID: 26742101
[TBL] [Abstract][Full Text] [Related]
4. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
[TBL] [Abstract][Full Text] [Related]
5. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.
Krois AS; Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1853-62. PubMed ID: 26976603
[TBL] [Abstract][Full Text] [Related]
6. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53.
Teufel DP; Freund SM; Bycroft M; Fersht AR
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7009-14. PubMed ID: 17438265
[TBL] [Abstract][Full Text] [Related]
7. Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex.
Tidow H; Melero R; Mylonas E; Freund SM; Grossmann JG; Carazo JM; Svergun DI; Valle M; Fersht AR
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12324-9. PubMed ID: 17620598
[TBL] [Abstract][Full Text] [Related]
8. Cancer-Associated Mutations Perturb the Disordered Ensemble and Interactions of the Intrinsically Disordered p53 Transactivation Domain.
Schrag LG; Liu X; Thevarajan I; Prakash O; Zolkiewski M; Chen J
J Mol Biol; 2021 Jul; 433(15):167048. PubMed ID: 33984364
[TBL] [Abstract][Full Text] [Related]
9. Structural convergence of unstructured p53 family transactivation domains in MDM2 recognition.
Shin JS; Ha JH; Lee DH; Ryu KS; Bae KH; Park BC; Park SG; Yi GS; Chi SW
Cell Cycle; 2015; 14(4):533-43. PubMed ID: 25591003
[TBL] [Abstract][Full Text] [Related]
10. Multiscale ensemble modeling of intrinsically disordered proteins: p53 N-terminal domain.
Terakawa T; Takada S
Biophys J; 2011 Sep; 101(6):1450-8. PubMed ID: 21943426
[TBL] [Abstract][Full Text] [Related]
11. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
[TBL] [Abstract][Full Text] [Related]
12. Domain-domain interactions in full-length p53 and a specific DNA complex probed by methyl NMR spectroscopy.
Bista M; Freund SM; Fersht AR
Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15752-6. PubMed ID: 22972749
[TBL] [Abstract][Full Text] [Related]
13. Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2.
Ferreon JC; Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6591-6. PubMed ID: 19357310
[TBL] [Abstract][Full Text] [Related]
14. Long-range modulation of chain motions within the intrinsically disordered transactivation domain of tumor suppressor p53.
Lum JK; Neuweiler H; Fersht AR
J Am Chem Soc; 2012 Jan; 134(3):1617-22. PubMed ID: 22176582
[TBL] [Abstract][Full Text] [Related]
15. Transactivation ability of p53 transcriptional activation domain is directly related to the binding affinity to TATA-binding protein.
Chang J; Kim DH; Lee SW; Choi KY; Sung YC
J Biol Chem; 1995 Oct; 270(42):25014-9. PubMed ID: 7559631
[TBL] [Abstract][Full Text] [Related]
16. Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein.
Lee CW; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2010 Nov; 49(46):9964-71. PubMed ID: 20961098
[TBL] [Abstract][Full Text] [Related]
17. Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR.
Krois AS; Park S; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2022 Dec; 61(23):2709-2719. PubMed ID: 36380579
[TBL] [Abstract][Full Text] [Related]
18. Wide-line NMR and DSC studies on intrinsically disordered p53 transactivation domain and its helically pre-structured segment.
Tompa P; Han KH; Bokor M; Kamasa P; Tantos Á; Fritz B; Kim DH; Lee C; Verebélyi T; Tompa K
BMB Rep; 2016 Sep; 49(9):497-501. PubMed ID: 27418282
[TBL] [Abstract][Full Text] [Related]
19. Dissecting functional roles of p53 N-terminal transactivation domains by microarray expression analysis.
Ohki R; Kawase T; Ohta T; Ichikawa H; Taya Y
Cancer Sci; 2007 Feb; 98(2):189-200. PubMed ID: 17233836
[TBL] [Abstract][Full Text] [Related]
20. The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.
Fadda E; Nixon MG
Phys Chem Chem Phys; 2017 Aug; 19(32):21287-21296. PubMed ID: 28597880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
